Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating deferasirox film-coated tablet versus phlebotomy in hereditary hemochromatosis was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemochromatosis

Drugs mentioned

• Deferasirox Film-coated Tablet (deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hereditary Hemochromatosis | Phase 2 | Status: TERMINATED | Results posted: 2024-06-07